公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
公司地址 250 Campus Drive, Marlborough, MA, USA, 01752
電話號碼 +1 508 263-2900
傳真號碼 --
公司網頁 https://www.hologic.com
員工數量 7070
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Jennifer Schneiders President, Diagnostics Solutions -- 16/01/2025
Mr. Brandon Schnittker Division President, GYN Surgical Solutions -- 16/01/2025
Mr. Mark Horvath Division President, Breast and Skeletal Health Solutions -- 16/01/2025
Mr. Stephen P. Macmillan Chairman of the Board, Chief Executive Officer and President 美元 1.21M 18/11/2025
Ms. Karleen M. Oberton Chief Financial Officer 美元 694.23K 18/11/2025
Ms. Diana De Walt Senior Vice President, Human Resources -- 16/01/2025
Mr. Benjamin J. Cohn Vice President, Corporate Controller and Principal Accounting Officer -- 18/11/2025
Mr. Jan Verstreken Group President, International 美元 693.40K 16/01/2025
Mr. Essex D. Mitchell Chief Operating Officer 美元 592.69K 16/01/2025
 
董事會成員
董事會 職務 更新日期
Ms. Stacey D. Stewart Independent Director 18/11/2025
Mr. Charles J. Dockendorff Independent Director 18/11/2025
Mr. Stephen P. Macmillan Chairman of the Board, Chief Executive Officer and President 18/11/2025
Ms. Amy A. Wendell Lead Independent Director 18/11/2025
Dr. Ludwig N. Hantson, PhD Independent Director 18/11/2025
Ms. Christiana Stamoulis, M.B.A. Independent Director 18/11/2025
Ms. Nanaz Mohtashami Independent Director 18/11/2025
Mr. Wayde D. McMillan Director 18/11/2025
Dr. Martin D. Madaus,PhD Director 18/11/2025
 
所屬ETF (更新日期: 07/03/2026 03:19)
代號 名稱 佔比% 持有日期
EOIEV Enhanced Equity Income<0.000001%30/11/2025
EOSEV Enhanced Equity Income II<0.000001%31/10/2025
EPSWisdomTree U.S. LargeCap Fund<0.000001%11/12/2025
ETJEV Risk-Mgd Divers Equity Inc<0.000001%30/11/2025
ETYEV Tax-Managed Div Equity Income<0.000001%30/11/2025
FABFirst Trust Multi Cap Val AlphaDEX® ETF<0.000001%08/01/2026
FCTRFirst Trust Lunt US Factor Rotation ETF<0.000001%04/09/2025
FEXFirst Trust Large Cap Core AlphaDEX® ETF<0.000001%08/01/2026
FLOWGlobal X U.S. Cash Flow Kings 100 ETF<0.000001%01/07/2025
FLSPFranklin Systematic Style Premia ETF<0.000001%17/02/2026
FORHFormidable ETF<0.000001%24/11/2025
FSCSFirst Trust SMID Capital Strength ETF<0.000001%20/07/2025
FTAFirst Trust Large Cap Val AlphaDEX® ETF<0.000001%08/01/2026
FXHFirst Trust Health Care AlphaDEX® ETF<0.000001%06/01/2026
GDEWisdomTree Efcnt Gld Pls Eq Stgy ETF<0.000001%15/12/2025
GEWCambria Global EW ETF<0.000001%20/10/2025
GSPYGotham Enhanced 500 ETF<0.000001%27/02/2026
GSUSGoldman Sachs MarketBeta US Equity ETF<0.000001%07/08/2025
GSWOGoldman Sachs ActiveBeta World Eq ETF<0.000001%07/08/2025
GVLUGotham 1000 Value ETF<0.000001%27/02/2026
  1    2    3    4    5    6    7    8    9    10   11    12    13    14  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.